Brofaromine is a reversible monoamine oxidase-A inhibitor (RIMA) investigated as an antidepressant offering a reduced dietary tyramine interaction risk compared with older irreversible MAOIs. Simson Pharma's Brofaromine reference standard supports research and comparative-pharmacology applications.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Brofaromine Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.